Alglucerase Overview Categories 99 Unassigned Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Alglucerase Manufacturers of Alglucerase Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Alglucerase's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage Alglucerase injection is administered by intravenous infusion over 1-2 hours. Dosage should be individualized for each patient. Initial dosage may be as little as 2.5 units/kg of body weight 3 times a week up to as much as 60 units/kg administered as frequently as once a week or as infrequently as every 4 weeks. 60 units/kg every 2 weeks is the dose for which the most data are available Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Alglucerase is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Alglucerase is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Alglucerase Back to top Manufacturers of Alglucerase in Pakistan Back to top Previous Drug Generic - Next Drug Generic